ICU Medical Inc ICUI

Morningstar Rating
$182.11 +3.26 (1.82%)
View Full Chart

Company Report

Price vs Fair Value

ICUI is trading at a LOCK|>!?&g premium.
Price
$182.11
Fair Value
LOCK|$c
Uncertainty
LOCK|X^
1-Star Price
LOCK|L.^
5-Star Price
LOCK|h.&<
Economic Moat
LOCK|<$
Capital Allocation
LOCK|>>tGn^K

Bulls Say, Bears Say

Bulls

Management has done an impressive job deepening ICU's consumables portfolio through acquisitions and bolstering its leading position in this attractive end market.

Bears

ICU has struggled to consolidate its Smiths Medical acquisition, which has led to additional restructuring costs and has cast doubt on the firm’s ability to successfully integrate acquisitions.

News

Articles & Videos

Trading Information

Previous Close Price
$178.85
Day Range
$176.86–183.03
52-Week Range
$113.37–192.85
Bid/Ask
$72.85 / $291.37
Shares Outstanding
25.01M
Market Cap
$4.55B
Volume/Avg
1,873 / 250,857

Key Statistics

Price/Earnings (Normalized)
21.99
Price/Sales
2.10
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Core
Total Number of Employees
13,000

Competitors

Valuation

Metric
ICUI
BAX
BDX
Price/Earnings (Normalized)
21.9912.9530.42
Price/Book Value
2.082.102.35
Price/Sales
2.101.173.06
Price/Cash Flow
12.5911.7316.28
Price/Earnings
ICUI
BAX
BDX

Financial Strength

Metric
ICUI
BAX
BDX
Quick Ratio
1.050.990.33
Current Ratio
2.371.790.87
Interest Coverage
1.380.214.15
Quick Ratio
ICUI
BAX
BDX

Profitability

Metric
ICUI
BAX
BDX
Return on Assets (Normalized)
3.76%4.82%—
Return on Equity (Normalized)
7.05%15.04%—
Return on Invested Capital (Normalized)
5.87%7.23%—
Return on Assets
ICUI
BAX
BDX

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
LOCK|%cdT$<$!LOCK|P!B$156B
Becton Dickinson & Co
BDX
LOCK|NbLOCK|@b<z$$58B
Alcon Inc
ALC
LOCK|H%r@X!LLOCK|mHz?J$36B
Medline Inc Ordinary Shares - Class A
MDLN
LOCK|&zg@kdpLOCK|XbM?$$36B
ResMed Inc
RMD
LOCK|WrR!Qt@YLOCK|R$d<&$33B
West Pharmaceutical Services Inc
WST
LOCK|@QWVD^nWLOCK|%?$29B
Solventum Corp
SOLV
LOCK|WQ?t>^LOCK|h@y$15B
Baxter International Inc
BAX
LOCK|!@&LOCK|%#@@>$14B
Align Technology Inc
ALGN
LOCK|#B@?Q#LOCK|rQZ%$12B
The Cooper Companies Inc
COO
LOCK|gzF&mrLOCK|>^YWF$12B

Sponsor Center